DAGL α Antibodies

Santa Cruz Biotechnology provides a broad selection of DAGL α monoclonal antibodies for research in lipid signaling and metabolism. DAGL α Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DAGL α, or diacylglycerol lipase alpha, plays a crucial role in the synthesis of endocannabinoids, which are important for various physiological processes, including pain modulation, appetite regulation, and neuroprotection. Understanding DAGL α function is essential for elucidating its involvement in neurodegenerative diseases and metabolic disorders. Research focused on DAGL α has revealed significant implications for therapeutic development in neurological conditions. Scientists studying DAGL α have uncovered important mechanisms in lipid metabolism and cellular signaling. Ongoing investigations of DAGL α continue to expand knowledge of endocannabinoid system regulation. Advanced research techniques have highlighted DAGL α's role in synaptic plasticity and neural development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DAGL α and its impact on human health.